Amrutanjan Health Care Limited

rs,

i 400 051 ISIN: INE098F01031 BSE Limited Department of Corporate Services 1st Floor, P.J. Towers, Dalal Street, Mumbai 400 001 Symbol: AMRUTANJAN Scrip Code: 590006 Dear Sir/ Madam, Sub: In

16%

h H1 FY ‘26 Brand Electro+ Growth H1 FY ‘26 Overall Pain Category Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contribut

21%

6 Brand Electro+ Growth H1 FY ‘26 Overall Pain Category Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contributed to the

7%

Growth H1 FY ‘26 Overall Pain Category Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contributed to the decline in perfor

9%

verall Pain Category Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contributed to the decline in performance Investor Pre

4%

egory Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contributed to the decline in performance Investor Presentation | Qua

24%

rivers (H1 FY’26): Growth led by Maha Strong and Back Pain Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Y

42%

Growth led by Maha Strong and Back Pain Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Year Ended 30th Sep

10%

ed by Maha Strong and Back Pain Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Year Ended 30th September 20

31%

ck Pain Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Year Ended 30th September 2025 Segment Performance:

26%

in Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Year Ended 30th September 2025 Segment Performance: Cong

28%

n’s Hygiene (Brand Comfy) Internal Gross Sales Growth Drivers (H1 FY26 Vs. SPLY): Relief Inhaler 28% Relief Mint Relief Rubs 2% 6% Internal Gross Sales Growth Drivers: Comfy XL Variant 44% Val

“Comfy XL Variant 44% Value Pack (18 Units Pack) 47% Increase in XL Variant’s contribution to Overall Comfy: 37% in H1 FY26 Vs 28% YA Investor Presentation | Quarter and Half Year Ended 30th September 2025 AHCL’s Growth Framework Key Growth Enablers Where to Play?”

“The flat growth of Comfy in Q2 FY26 is on account of Quantity Purchase Scheme (QPS) were given as products has been changed to credit note.”

“(Refer note in Slide # 22 & 25 on this) Investor Presentation | Quarter and Half Year Ended 30th September 2025 Financials – Q2 FY26 (Rs.”

“in Crores) Net Sales 117.70 109.92 Profit Before Tax 19.21 15.94 Profit After Tax 13.96 11.80 Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 Growth: 7.08% Growth: 20.51% Growth: 18.31% Investor Presentation | Quarter and Half Year Ended 30th September 2025 ParticularsQ2 FY26Q2 FY25GrowthRevenue from Operations117.70 109.92 7.08%Less : Other Operating Revenue0.27 0.30 Add : IND AS 115 adjustments6.08 2.00 Add : GST8.99 9.10 Gross Sales132.49 120.71 9.76% Financials – Q2 FY26 (Rs.”

“in Crores) Net Sales 211.75 193.65 30.51 22.27 Profit Before Tax Profit After Tax 22.29 16.41 H1 FY26 H1 FY25 H1 FY26 H1 FY25 H1 FY26 H1 FY25 Growth: 9.35% Growth: 36.88% Growth: 35.71% Investor Presentation | Quarter and Half Year Ended 30th September 2025 ParticularsH1 FY26H1 FY25GrowthRevenue from Operations211.75 193.65 9.35%Less : Other Operating Revenue0.42 0.54 Add : IND AS 115 adjustments11.62 5.10 Add : GST16.73 16.05 Gross Sales239.68 214.27 11.86% Financials – H1 FY26 (Rs.”

“in Crores) Net Sales - OTC 198.38 178.89 Gross Sales - OTC H1 FY26 H1 FY25 Growth: 10.89% Net Sales – Comfy (Included in above) 61.39 59.58 H1 FY26 H1 FY25 Growth: 3.04% Gross Sales – Comfy (Included in above) * Increase in current year is on account of Quantity Purchase Scheme(QPS) was converted from Products to Credit note”

“• Majority of raw material prices are lower than H1 FY25.”

“Menthol Crystal price is marginally higher than H1 FY25.”

“Packing material prices are marginally higher than H1 FY25.”

“• Advertisement spend for H1 FY26 is at Rs.”

Notes

2

Management

1

Congestion

1

Rehydration

1

Internal Gross Sales Growth Drivers

1

Activity

1

Note on Comfy revenue growth

1

Congestion

6.8 Crs Women’s Hygiene: 66.6 Crs Brand Comfy Investor Presentation | Quarter and Half Year Ended 30th September 2025

Rehydration

13.6 Crs Brand Electro+ H1 FY 25-26: Pain Management (Gross Sales Growth) – Continued momentum in Q2 enabled good double digit growth in H1 Pain Management Congestion Women’s Hygiene Rehydration Brand Amrutanjan Brand Relief Brand Comfy Growth H1 FY ‘26 Growth H1 FY ‘26 Growth H1 FY ‘26 Brand Electro+ Growth H1 FY ‘26 Overall Pain Category Head Category Body Category 16% 16% 21% Relief Range 7% Overall Comfy 9% Electro+ -4% Category-specific factors contributed to the decline in performance Investor Presentation | Quarter and Half Year Ended 30th September 2025 Segment Performance: Pain Management Head Category (Brand Amrutanjan) Body Category (Brand Amrutanjan) Internal Gross Growth Drivers (H1 FY‘26): All SKUs Contributed to the growth Internal Gross Sales Growth Drivers (H1 FY’26): Growth led by Maha Strong and Back Pain Roll On (BPRO) Big SKUs (27.5ml & 50ml) 24% Head Roll On 42% 8ml 10% Maha Strong BPRO 31% 26% Investor Presentation | Quarter and Half Year Ended 30th September 202

Internal Gross Sales Growth Drivers

Comfy XL Variant 44% Value Pack (18 Units Pack) 47% Increase in XL Variant’s contribution to Overall Comfy: 37% in H1 FY26 Vs 28% YA Investor Presentation | Quarter and Half Year Ended 30th September 2025 AHCL’s Growth Framework Key Growth Enablers Where to Play? • • Increase market share in our existing markets Invest and develop low contributing markets • Build new categories and formats How to win? • TV media with high impact properties • Digitally Integrated Communication Strategy – Highest investment planned for this year • On-ground and In-shop visibility • Trial generation activities – Consumers tend to consider the brand after the activity Investor Presentation | Quarter and Half Year Ended 30th September 2025 Marketing Interventions: Head and Body TV Campaign • Two new films were developed with multiple Category Entry Points (CEPs) to connect with larger base of the audience • Products Covered: Yellow and White Balms and Headache Roll On • The ads highlighted the usage occasio

Activity

• Sampling and Physiotherapy activity in Marathons • In addition, a mega sampling activity was undertaken through Quick Commerce, wherein 3L consumers were reached directly. In addition to sampling, education posters highlighting the usage occasions of WHO ORS and non-WHO ORS Rehydration drinks were also given along with the sample Markets: Across all Key markets Investor Presentation | Quarter and Half Year Ended 30th September 2025 Counter Top Unit – Education Cum Visibility Operations Update – Sales and Distribution Sales – Execution Excellence In alignment with our vision to accelerate growth, targeted execution enhancement initiatives were implemented to strengthen operational efficiency. As a result, most key sales metrics recorded positive momentum during the quarter Manpower Consolidate Managers and Increase the Feet- on-Street Internal Sales Value Increased by 37% Productive Calls Increased by 7% Manpower Productivity Increased by 16% Total Lines Sold Increased by 35% Closing

Note on Comfy revenue growth

The flat growth of Comfy in Q2 FY26 is on account of Quantity Purchase Scheme (QPS) were given as products has been changed to credit note. (Refer note in Slide # 22 & 25 on this) Investor Presentation | Quarter and Half Year Ended 30th September 2025 Financials – Q2 FY26 (Rs. in Crores) Net Sales 117.70 109.92 Profit Before Tax 19.21 15.94 Profit After Tax 13.96 11.80 Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 Q2 FY25 Growth: 7.08% Growth: 20.51% Growth: 18.31% Investor Presentation | Quarter and Half Year Ended 30th September 2025 ParticularsQ2 FY26Q2 FY25GrowthRevenue from Operations117.70 109.92 7.08%Less : Other Operating Revenue0.27 0.30 Add : IND AS 115 adjustments6.08 2.00 Add : GST8.99 9.10 Gross Sales132.49 120.71 9.76% Financials – Q2 FY26 (Rs. in Crores) Net Sales - OTC 112.80 106.26 Q2 FY26 Q2 FY25 Growth: 6.15% Net Sales - Comfy (Included in above) 32.78 33.00 Q2 FY26 Q2 FY25 Investor Presentation | Quarter and Half Year Ended 30th September 2025 Gross Sales - OTC Gross Sale

Notes

• Majority of raw material prices are lower than H1 FY25. Menthol Crystal price is marginally higher than H1 FY25. Packing material prices are marginally higher than H1 FY25. • Advertisement spend for H1 FY26 is at Rs. 10.63 Cr against Rs. 11.88 Cr for H1 FY25. Advertisement spend for Comfy is at Rs. 2.71 Cr for H1 FY26 against Rs. 2.41 Cr for H1 FY25. Investor Presentation | Quarter and Half Year Ended 30th September 2025 ParticularsH1 FY26H1 FY25GrowthRevenue from Operations198.38 178.89 10.89%Less : Other Operating Revenue0.38 0.47 Add : IND AS 115 adjustments10.05 4.38 Add : GST15.37 14.24 Gross Sales223.42 197.05 13.38%ParticularsH1 FY26H1 FY25GrowthRevenue from Operations61.39 59.58 3.04%Add : IND AS 115 adjustments *5.25 1.39 Gross Sales66.64 60.97 9.30% Financials – H1 FY26 (Rs. in Crores) Net Sales - Beverages 14.34 12.05 H1 FY26 H1 FY25 Net Sales - Electro Plus (Included in above) 10.78 11.88 H1 FY26 H1 FY25 Gross Sales - Beverages Gross Sales – Electro Plus (Included in abov